Back to results
US 2021/0070744 A1Published application
Heterocyclic rip1 kinase inhibitors
AssigneeRigel Pharmaceuticals, Inc.
InventorsSimon Shaw, Somasekhar Bhamidipati, Vanessa Taylor
Life of this patent
Estimating the term…
Abstract
Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition.
Claims46
A compound, according to Formula I
- or a pharmaceutically acceptable salt, N-oxide, solvate, tautomer, or stereoisomer thereof, wherein:
- ring B is heteroaryl;
- each R1 independently is halogen or -linker-R6 group, wherein the linker is a bond or Ra, provided that Ra is not H or D, and R6 is heterocyclyl, Rb, —C(Rf)3, or —C(Rf)═C(Rf)2;
- R2 is Ra;
- R3 is Ra;
- if present, each R4 independently is Re;
- L is a heteroatom or Ra, provided that Ra is not H or D;
- X is CH2 or O;
- Z is heteroaryl;
- m is 1, 2, 3, or 4;
- n is 0, 1 or 2;
- Ra is independently for each occurrence H or D, except for embodiments where L is Ra, C1-10aliphatic, C1-10haloaliphatic, C5-10aromatic, C3-6heterocyclic, or C3-10spiroheterocyclic;
- Rb is independently for each occurrence —OH, —SH, —OR′, —SRc, —NRdRd, —Si(Ra)3, —C(O)OH, —C(O)ORc, —C(O)NRdRd, —OC(O)NRdRd, —OC(O)C1-10alkyl substituted with one or two NRdRd, carboxyl, or a combination thereof, and optionally further substituted with an aromatic moiety, —SH, —O-acyl, or —C(O)NH2;
- Rc is independently for each occurrence C1-10alkyl, which can be substituted with 1, 2 or 3 Re, C2-10alkenyl, which can be substituted with 1, 2 or 3 Re, C2-10alkynyl, which can be substituted with 1, 2 or 3 Re, C3-6cycloalkyl, which can be substituted with 1, 2 or 3 Re, or C5-10aromatic, which can be substituted with 1, 2 or 3 Re;
- Rd is independently for each occurrence H;
- C1-6alkyl, which can be substituted with 1, 2 or 3 Re or a C3-9heterocyclyl;
- C3-6cycloalkyl, which can be substituted with 1, 2 or 3 Re;
- C3-6heterocyclic, which can be substituted with 1, 2 or 3 Re;
- C5-10aryl, which can be substituted with 1, 2 or 3 Rb;
- C5-10heteroaryl, which can be substituted with 1, 2 or 3 Re;
- or two Ra groups together with the nitrogen bound thereto provide a C3-9heterocyclic, which can be substituted with one or more Re), or a C5-10heteroaryl, which can be substituted with one or more Re;
- Re is independently for each occurrence halogen, C1-6alkyl, C2-10alkenyl, C2-10alkynyl, C1-6haloalkyl, C3-6cycloalkyl, C5-10heteroaryl, or —ORa;
- and
- Rf is independently for each occurrence -alkyl-phosphate, Ra, Rb, or Re, or two Rf groups together with the carbon atom bound thereto provide a C2-6alkenyl group, a C3-6cycloalkyl group, which can be substituted with one or more Re, or a C3-10heterocyclic, which can be substituted with one or more Re or acyl.
21 more elements
Dependencies are inferred from the claim text.